Celera Expects to Become Profitable in June | GenomeWeb

NEW YORK, Oct. 8 - Celera Genomics' online database business will become profitable by the end of June 2002, Chief Business Officer Peter Barrett told an investor conference here on Monday.

He added that Celera’s acquisition of Axys Pharmaceuticals, announced in June 2001, is expected to close during the current quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.